Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma

Catalina Amador-Ortiz, Charles L. Goolsby, Loann C. Peterson, Kristy L. Wolniak, Janet L. McLaughlin, Juehua Gao, Yi Hua Chen

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Objectives: Nuclear overexpression of lymphoid enhancerbinding factor 1 (LEF1) assessed by immunohistochemistry has been shown to be highly associated with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) among small B-cell lymphomas. The purpose of this study was to evaluate the utility of flow cytometric analysis of LEF1 in the diagnosis of CLL/SLL. Methods: Normal peripheral blood was used to validate the test. Flow cytometric analysis of LEF1 was performed in 64 patient samples qualitatively and quantitatively by comparing the staining intensity and the ratios of the median fluorescence intensities (MFIs) of LEF1 in B cells of interest to the internal reference cell populations. The results were correlated with the pathologic diagnosis. Results: Proper sample processing ensured sufficient separation of positive LEF1 staining in T cells from negative staining in normal B and natural killer (NK) cells. Qualitative analysis of patient samples showed that all 25 cases of CLL/SLL but none of the other small B-cell lymphomas were positive for LEF1. Using a B/NK MFI ratio of 1.5 and B/T MFI ratio of 0.45 separated CLL/SLL cases from non-CLL lymphomas. Conclusions: Flow cytometric analysis of LEF1 is sufficient to differentiate CLL/SLL from other small B-cell lymphomas and may serve as a useful tool in the diagnosis of CLL/SLL.

Original languageEnglish (US)
Pages (from-to)214-222
Number of pages9
JournalAmerican journal of clinical pathology
Volume143
Issue number2
DOIs
StatePublished - Feb 1 2015

Fingerprint

Lymphoid Enhancer-Binding Factor 1
B-Cell Chronic Lymphocytic Leukemia
B-Cell Lymphoma
Fluorescence
Staining and Labeling

Keywords

  • Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
  • Flow cytometry
  • LEF1

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma. / Amador-Ortiz, Catalina; Goolsby, Charles L.; Peterson, Loann C.; Wolniak, Kristy L.; McLaughlin, Janet L.; Gao, Juehua; Chen, Yi Hua.

In: American journal of clinical pathology, Vol. 143, No. 2, 01.02.2015, p. 214-222.

Research output: Contribution to journalArticle

Amador-Ortiz, Catalina ; Goolsby, Charles L. ; Peterson, Loann C. ; Wolniak, Kristy L. ; McLaughlin, Janet L. ; Gao, Juehua ; Chen, Yi Hua. / Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma. In: American journal of clinical pathology. 2015 ; Vol. 143, No. 2. pp. 214-222.
@article{c4092a83d3a44f788c804a0b6183b718,
title = "Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma",
abstract = "Objectives: Nuclear overexpression of lymphoid enhancerbinding factor 1 (LEF1) assessed by immunohistochemistry has been shown to be highly associated with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) among small B-cell lymphomas. The purpose of this study was to evaluate the utility of flow cytometric analysis of LEF1 in the diagnosis of CLL/SLL. Methods: Normal peripheral blood was used to validate the test. Flow cytometric analysis of LEF1 was performed in 64 patient samples qualitatively and quantitatively by comparing the staining intensity and the ratios of the median fluorescence intensities (MFIs) of LEF1 in B cells of interest to the internal reference cell populations. The results were correlated with the pathologic diagnosis. Results: Proper sample processing ensured sufficient separation of positive LEF1 staining in T cells from negative staining in normal B and natural killer (NK) cells. Qualitative analysis of patient samples showed that all 25 cases of CLL/SLL but none of the other small B-cell lymphomas were positive for LEF1. Using a B/NK MFI ratio of 1.5 and B/T MFI ratio of 0.45 separated CLL/SLL cases from non-CLL lymphomas. Conclusions: Flow cytometric analysis of LEF1 is sufficient to differentiate CLL/SLL from other small B-cell lymphomas and may serve as a useful tool in the diagnosis of CLL/SLL.",
keywords = "Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), Flow cytometry, LEF1",
author = "Catalina Amador-Ortiz and Goolsby, {Charles L.} and Peterson, {Loann C.} and Wolniak, {Kristy L.} and McLaughlin, {Janet L.} and Juehua Gao and Chen, {Yi Hua}",
year = "2015",
month = "2",
day = "1",
doi = "10.1309/AJCPT32JDFIGHFHJ",
language = "English (US)",
volume = "143",
pages = "214--222",
journal = "American Journal of Clinical Pathology",
issn = "0002-9173",
publisher = "American Society of Clinical Pathologists",
number = "2",

}

TY - JOUR

T1 - Flow cytometric analysis of lymphoid enhancer-binding factor 1 in diagnosis of chronic lymphocytic leukemia/small lymphocytic lymphoma

AU - Amador-Ortiz, Catalina

AU - Goolsby, Charles L.

AU - Peterson, Loann C.

AU - Wolniak, Kristy L.

AU - McLaughlin, Janet L.

AU - Gao, Juehua

AU - Chen, Yi Hua

PY - 2015/2/1

Y1 - 2015/2/1

N2 - Objectives: Nuclear overexpression of lymphoid enhancerbinding factor 1 (LEF1) assessed by immunohistochemistry has been shown to be highly associated with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) among small B-cell lymphomas. The purpose of this study was to evaluate the utility of flow cytometric analysis of LEF1 in the diagnosis of CLL/SLL. Methods: Normal peripheral blood was used to validate the test. Flow cytometric analysis of LEF1 was performed in 64 patient samples qualitatively and quantitatively by comparing the staining intensity and the ratios of the median fluorescence intensities (MFIs) of LEF1 in B cells of interest to the internal reference cell populations. The results were correlated with the pathologic diagnosis. Results: Proper sample processing ensured sufficient separation of positive LEF1 staining in T cells from negative staining in normal B and natural killer (NK) cells. Qualitative analysis of patient samples showed that all 25 cases of CLL/SLL but none of the other small B-cell lymphomas were positive for LEF1. Using a B/NK MFI ratio of 1.5 and B/T MFI ratio of 0.45 separated CLL/SLL cases from non-CLL lymphomas. Conclusions: Flow cytometric analysis of LEF1 is sufficient to differentiate CLL/SLL from other small B-cell lymphomas and may serve as a useful tool in the diagnosis of CLL/SLL.

AB - Objectives: Nuclear overexpression of lymphoid enhancerbinding factor 1 (LEF1) assessed by immunohistochemistry has been shown to be highly associated with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) among small B-cell lymphomas. The purpose of this study was to evaluate the utility of flow cytometric analysis of LEF1 in the diagnosis of CLL/SLL. Methods: Normal peripheral blood was used to validate the test. Flow cytometric analysis of LEF1 was performed in 64 patient samples qualitatively and quantitatively by comparing the staining intensity and the ratios of the median fluorescence intensities (MFIs) of LEF1 in B cells of interest to the internal reference cell populations. The results were correlated with the pathologic diagnosis. Results: Proper sample processing ensured sufficient separation of positive LEF1 staining in T cells from negative staining in normal B and natural killer (NK) cells. Qualitative analysis of patient samples showed that all 25 cases of CLL/SLL but none of the other small B-cell lymphomas were positive for LEF1. Using a B/NK MFI ratio of 1.5 and B/T MFI ratio of 0.45 separated CLL/SLL cases from non-CLL lymphomas. Conclusions: Flow cytometric analysis of LEF1 is sufficient to differentiate CLL/SLL from other small B-cell lymphomas and may serve as a useful tool in the diagnosis of CLL/SLL.

KW - Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)

KW - Flow cytometry

KW - LEF1

UR - http://www.scopus.com/inward/record.url?scp=84925284056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925284056&partnerID=8YFLogxK

U2 - 10.1309/AJCPT32JDFIGHFHJ

DO - 10.1309/AJCPT32JDFIGHFHJ

M3 - Article

C2 - 25596247

AN - SCOPUS:84925284056

VL - 143

SP - 214

EP - 222

JO - American Journal of Clinical Pathology

JF - American Journal of Clinical Pathology

SN - 0002-9173

IS - 2

ER -